The increased insulin, glucose, and HOMA-IR of the High22 group mirrors the obesity-driven phenotype of HFD mice, whereas the presence of hepatic steatosis without major alterations in glucose and lipid metabolism in the Low22 group is similar to the phenotype of SAC mice. Here, INS is linked to fatty liver disease.